• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: COOK IRELAND LTD RESONANCE STENT SET; FAD STENT, URETERAL

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

COOK IRELAND LTD RESONANCE STENT SET; FAD STENT, URETERAL Back to Search Results
Catalog Number UNKNOWN
Device Problem Adverse Event Without Identified Device or Use Problem (2993)
Patient Problem Unspecified Kidney or Urinary Problem (4503)
Event Date 06/03/2020
Event Type  Injury  
Manufacturer Narrative
Investigation is still pending, a follow-up mdr report will be submitted to include the investigation conclusions.
 
Event Description
Ho et al 2020 - risk factors in the prediction of long-term patency of resonance metallic ureteric stent in malignant ureteric obstruction this study aimed to identify risk factors associated with resonance metallic ureteric stent failure due to malignant disease progression, and to propose a simple scoring system for the prediction of long-term patency of metallic stent in patients with muo.Resonance metallic ureteric stents were inserted in a standardized retrograde fashion under both cystoscopic and fluoroscopic guidance.Retrograde pyelogram was first carried out in all patients to confirm level of obstruction.Ureteric length was measured by catheterizing the ureter with an open ended ureteric catheter marked with a visual scale measurer.Gentle ureteric dilation (either by balloon or teflon ureteric dilators) was performed at the discretion of the operating surgeon if required.Insertion of resonance metallic ureteric stents were as per manufacturer's instructions.The position of the proximal coil of the metallic ureteric stents were confirmed with fluoroscopy and distal coil by cystoscopy.All metallic ureteric stents used were 6 fr in size, with lengths measuring from 22 to 26 cm chosen according to ureteric length measured.All metallic ureteric stents were revised yearly as per manufacturer's recommendations.This file will capture the storage bladder symptoms.Stent removal.
 
Event Description
Supplemental follow-up mdr report is being submitted due to the completion of the investigation and an update to the investigation conclusions.
 
Manufacturer Narrative
Device evaluation this file was opened to capture urinary symptoms experienced by a patient after stenting in the literature ¿ho et al 2020 - risk factors in the prediction of long-term patency of resonance metallic ureteric stent in malignant ureteric obstruction¿ furthermore, the below files have also been created as a result of the literature article and are related to this occurrence: (b)(4).(emdr ref.-3001845648-2022-00633) - ho et al 2020 -stent obstruction (b)(4).(emdr ref.-3001845648-2022-00640) - ho et al 2020 -stent removal (vesicorectal fistula).The unknown device of unknown lot number involved in this complaint was not available for evaluation.With the information provided, a document-based investigation was conducted.Lab evaluation: the device evaluation could not be completed as the device or photographic evidence of the device was not returned for evaluation.Document review: manufacturing records review could not be completed as the lot number is unknown.However, prior to distribution all rms devices are subject to visual a visual inspection and functional checks to ensure device integrity.These inspections and functional checks are outlined in internal procedures in place at cirl.Review of historical data: historical data was not reviewed as the lot number is unknown.It should be noted that the instructions for use states the following: ¿potential adverse events associated with indwelling ureteral stents include: infections, urinary symptoms (frequency, urgency, incontinence, dysuria, haematuria), urinary tract tissue erosion¿.¿warnings individual variations of interaction between stents and urinary system are unpredictable¿ there is no evidence to suggest that the customer did not follow the instructions for use.Image review: an image was not returned for evaluation.Root cause review: a definitive root cause could not be determined from the available information.A possible root cause could be attributed to the stenting procedure.Urinary symptoms are a known potential adverse event of stenting with the rms device.Summary: complaint is confirmed based on customer and/or rep testimony.According to literature paper, the patient could not tolerate the symptoms associated with the rms device and required secondary intervention for stent removal.Complaints of this nature will continue to be monitored for potential emerging trends.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
RESONANCE STENT SET
Type of Device
FAD STENT, URETERAL
Manufacturer (Section D)
COOK IRELAND LTD
o halloran road
limerick
Manufacturer (Section G)
COOK IRELAND LTD
o halloran road
national technology park
limerick
Manufacturer Contact
sinead o'leary
o halloran road
national technology park
limerick 
MDR Report Key16730434
MDR Text Key313189926
Report Number3001845648-2023-00230
Device Sequence Number1
Product Code FAD
Combination Product (y/n)N
PMA/PMN Number
K063742
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Literature
Reporter Occupation Physician
Type of Report Initial,Followup
Report Date 05/12/2023
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Health Professional
Device Catalogue NumberUNKNOWN
Device Lot NumberUNKNOWN
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Was the Report Sent to FDA? No
Distributor Facility Aware Date06/03/2020
Event Location Hospital
Initial Date Manufacturer Received 03/15/2023
Initial Date FDA Received04/13/2023
Supplement Dates Manufacturer Received03/15/2023
Supplement Dates FDA Received06/09/2023
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Patient Outcome(s) Required Intervention;
Patient Age62 YR
Patient SexFemale
-
-